Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
about
Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@en
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@nl
type
label
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@en
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@nl
prefLabel
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@en
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@nl
P2093
P2860
P1433
P1476
Complement-dependent cytotoxic ...... e-bound complement inhibitors.
@en
P2093
Bart A Nijmeijer
Constantijn J Halkes
H M Esther van Egmond
Inge Jedema
J H Frederik Falkenburg
P2860
P356
10.1080/10428194.2017.1281411
P577
2017-01-31T00:00:00Z